Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|September 1, 2019
From presentation to paper: Gender disparities in oncological researchWillemieke P M Dijksterhuis, Charlotte I Stroes, Wan-Ling Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2020
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4+PD-1+ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple MyelomaNouf Alrasheed, Lydia Lee, Ehsan Ghorani, et al.
ESMO Open|December 20, 2021
Female leadership in oncology-has progress stalled? Data from the ESMO W4O authorship and monitoring studiesA S Berghoff, C Sessa, J C-H Yang, et al.
ESMO Open|February 26, 2023
Challenges in oncology career: are we closing the gender gap? Results of the new ESMO Women for Oncology Committee surveyH Linardou, A A Adjei, J Bajpai, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 studyJason Chesney, Karl D Lewis, Harriet Kluger, et al.
The Journal of Experimental Medicine|September 28, 2018
Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironmentYien Ning Sophia Wong, Kroopa Joshi, Pramit Khetrapal, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2014
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanomaSander Kelderman, Bianca Heemskerk, Harm van Tinteren, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Cancer Discovery|January 9, 2025
Tracking Nongenetic Evolution from Primary to Metastatic ccRCC: TRACERx RenalÁngel Fernández-Sanromán, Annika Fendler, Benjy J Y Tan, et al.
Journal for Immunotherapy of Cancer|June 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanomaJames William Smithy, Allison Betof, Sebastian Klobuch, et al.
Pageof 5